Browsing Tag
Myovant Sciences
2 posts
From healthtech to AI: What Kartika Saran’s CFO move reveals about SPARC’s ambitions
SPARC AI names Kartika Saran as CFO in a move signaling strategic capital readiness. Read why this hire may reshape its investor strategy and scaling plan.
Sumitovant Biopharma to take full ownership of Myovant Sciences for $1.7bn
Sumitovant Biopharma, a subsidiary of Japan-based Sumitomo Pharma (previously Sumitomo Dainippon Pharma), is set to take full ownership…